ACC 2021: Investigational Evinacumab Shows Promise for Select Patients With Severe Hypertriglyceridemia
The drug is not effective in patients with familial chylomicronemia syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.